TheraVasc's Unattributed VC Round

TheraVasc raised a round of funding on November 15, 2013. Investors include Portal Capital.

TheraVasc is a privately-held biotechnology company with offices in Louisiana, focused on the development of vascular therapies with decreased risks through the repositioning of drugs with known safet…

Articles about TheraVasc's Unattributed VC Round: